Kirin and Astellas Enter Into a Licensing Agreement on an Immunosuppressive Fully Human Monoclonal Antibody
Kirin Brewery Company, Limited and Astellas Pharma Inc. announced today that they have entered into a license and collaborative research and development agreement.
Sanofi-aventis and Kyowa Hakko Kirin enter into a Collaboration and Licensing Agreement on an Anti LIGHT fully human monoclonal antibody
Paris, France – May 14, 2009 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Kyowa Hakko Kirin Co., Ltd. (Kyowa
LA JOLLA, CA—Follicular helper T cells (Tfh cells), a rare type of T cells, are indispensible for the maturation of
SAN DIEGO – (January 10th, 2013) Renowned scientist Leroy Hood, M.D., Ph.D., a member of the Board of Directors of